BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16259283)

  • 1. [New diagnostic markers: podoplanin-d2-40].
    Chilosi M; Doglioni C; Dei Tos AP
    Pathologica; 2005 Jun; 97(3):158-9. PubMed ID: 16259283
    [No Abstract]   [Full Text] [Related]  

  • 2. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
    Ordóñez NG
    Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podoplanin: a novel diagnostic immunohistochemical marker.
    Ordóñez NG
    Adv Anat Pathol; 2006 Mar; 13(2):83-8. PubMed ID: 16670463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the colorectal antigen IOR C2.II.
    Vázquez AM; Tormo B; Velandia A; Gómez CA; Alfonso M; Giscombe R; Ansotegui I; Jeddi-Tehrani M; Pérez R; Mellstedt H
    Year Immunol; 1993; 7():137-45. PubMed ID: 7690506
    [No Abstract]   [Full Text] [Related]  

  • 5. Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours.
    Sonne SB; Herlihy AS; Hoei-Hansen CE; Nielsen JE; Almstrup K; Skakkebaek NE; Marks A; Leffers H; Rajpert-De Meyts E
    Virchows Arch; 2006 Aug; 449(2):200-6. PubMed ID: 16736189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic vessels identified with podoplanin. Comparison of immunostaining with three different detection systems.
    Cîmpean AM; Raica M; Izvernariu DA; Tătucu D
    Rom J Morphol Embryol; 2007; 48(2):139-43. PubMed ID: 17641800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis.
    Ohno F; Nakanishi H; Abe A; Seki Y; Kinoshita A; Hasegawa Y; Tatematsu M; Kurita K
    J Oral Pathol Med; 2007 May; 36(5):281-9. PubMed ID: 17448138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse membranous immunoreactivity for podoplanin (D2-40) distinguishes primary and metastatic seminomas from other germ cell tumors and metastatic neoplasms.
    Yu H; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):767-75. PubMed ID: 17951198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics.
    Gomaa AH; Yaar M; Bhawan J
    Am J Dermatopathol; 2007 Feb; 29(1):18-21. PubMed ID: 17284957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D2-40 and cutaneous epithelioid angiomatous nodule.
    Fernandez-Flores A
    Am J Dermatopathol; 2008 Jun; 30(3):302-4. PubMed ID: 18496440
    [No Abstract]   [Full Text] [Related]  

  • 11. The identification and development of specific monoclonal antibodies to squamous cell carcinoma.
    Arlen M; Tsang A; Scherrer J; Wolf J; Saric O
    Crit Rev Immunol; 2001; 21(1-3):205-14. PubMed ID: 11642605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2-40 immunohistochemistry--so far!
    Kalof AN; Cooper K
    Adv Anat Pathol; 2009 Jan; 16(1):62-4. PubMed ID: 19098468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
    Yu H; Gibson JA; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):776-82. PubMed ID: 17951199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2-40 labeling in lymphangiomyoma/lymphangiomyomatosis of the soft tissue: further evidence of lymphangiogenic tumor histogenesis.
    Hansen T; Katenkamp K; Bittinger F; Kirkpatrick CJ; Katenkamp D
    Virchows Arch; 2007 Apr; 450(4):449-53. PubMed ID: 17377811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunohistochemistry of malignant mesothelioma.
    Leong AS; Vernon-Roberts E
    Pathol Annu; 1994; 29 ( Pt 2)():157-79. PubMed ID: 7936746
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monoclonal antibodies as antineoplastic antibodies].
    Hashimoto Y
    Nihon Rinsho; 1983; 41(4):821-4. PubMed ID: 6887550
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic utility of D2-40 and podoplanin in effusion cell blocks.
    Bhalla R; Siddiqui MT; Mandich D; Cartun RW; Fiel-Gan MD; Nassar A; Mandavilli SR
    Diagn Cytopathol; 2007 Jun; 35(6):342-7. PubMed ID: 17497664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of lymphangiogenesis as assessed by immunohistochemistry for podoplanin in patients with esophageal carcinoma.
    Nakayama Y; Matsumoto K; Nagato M; Inoue Y; Katsuki T; Minagawa N; Shibao K; Tsurudome Y; Hirata K; Higure A; Sako T; Nagata N
    Anticancer Res; 2007; 27(1B):619-25. PubMed ID: 17348451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The evaluation of the efficiency in the detection of embryonal cancer and tumor-related antigens as tumor markers in gastrointestinal cancer].
    Cheshenko VP
    Klin Khir; 1998; (5):20-1. PubMed ID: 9787561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic differentiation in renal angiomyolipomas.
    Bonsib SM; Moghadamfalahi M; Bhalodia A
    Hum Pathol; 2009 Mar; 40(3):374-80. PubMed ID: 18973924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.